Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 24

    Aurobindo Pharma receives USFDA Approval for Levetiracetam in Sodium Chloride Injection

    Aurobindo Pharma receives USFDA Approval for Levetiracetam in Sodium Chloride Injection

    supriya15 Jan 2017 12:54 PM IST
    Hyderabad : Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration...
    USFDA Accepts BLA for Mylan and Biocon

    USFDA Accepts BLA for Mylan and Biocon's Proposed Biosimilar Trastuzumab

    supriya12 Jan 2017 11:22 AM IST
    Bengaluru : Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration has accepted Mylan's biologics license application (BLA)...
    Intas Pharmaceuticals Completes Deal to Acquire Actavis UK,Ireland Generics Businesses From Teva

    Intas Pharmaceuticals Completes Deal to Acquire Actavis UK,Ireland Generics Businesses From Teva

    supriya11 Jan 2017 11:09 AM IST
    Ahmedabad : Intas Pharmaceuticals Ltd. through its wholly-owned subsidiary Accord Healthcare Ltd. announced it has completed the deal to acquire...
    FDA Grants Bayer Priority Review for Stivarga-regorafeni for the Second-Line Systemic Treatment of Liver Cancer

    FDA Grants Bayer Priority Review for Stivarga-regorafeni for the Second-Line Systemic Treatment of Liver Cancer

    supriya11 Jan 2017 11:08 AM IST
    Whippany : Bayer announced that the U.S. Food and Drug Administration (FDA) has granted priority review status for the supplemental New Drug...
    Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017

    Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017

    supriya kashyap kashyap7 Jan 2017 11:45 AM IST
    Paris : Sanofi and Boehringer Ingelheim confirmed that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi’s...
    Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT Phase I Trial

    Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT Phase I Trial

    supriya kashyap kashyap7 Jan 2017 11:45 AM IST
    Mahwah : Glenmark Pharmaceuticals, a global pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) cleared the Company's...
    Practo Ray Tab Introduces Digital Consent Forms for the first time in India

    Practo Ray Tab Introduces Digital Consent Forms for the first time in India

    supriya kashyap kashyap7 Jan 2017 11:45 AM IST
    Bangalore : Practo, the leading digital healthcare platform has announced the integration of consent forms into the Practo Ray Tab for the first time....
    Sun Pharma shows Positive Results in Phase-3 Clinical Trial for Dry Eye drug

    Sun Pharma shows Positive Results in Phase-3 Clinical Trial for Dry Eye drug

    supriya kashyap kashyap6 Jan 2017 10:45 AM IST
    Seciera™ Meets Primary and Key Secondary Endpoints in Pivotal Trial Shows Efficacy at 12 Weeks of Treatment Sun Pharma is Developing Seciera™ for...
    Sanofi Pasteur and MSD end joint vaccines business in Europe

    Sanofi Pasteur and MSD end joint vaccines business in Europe

    supriya kashyap kashyap6 Jan 2017 10:43 AM IST
    Paris : Sanofi and its vaccines global business unit Sanofi Pasteur confirmed the end of their vaccine joint-venture with MSD (known as Merck &...
    Suven Life Sciences secures two Product Patents in Eurasia and Norway

    Suven Life Sciences secures two Product Patents in Eurasia and Norway

    supriya kashyap kashyap4 Jan 2017 12:02 PM IST
    Hyderabad : Suven Life Sciences Ltd announces that the grant of one (1) product patent from Eurasia (025136) and one (1) product patent from Norway...
    Masimo launches advanced monitoring technologies in India

    Masimo launches advanced monitoring technologies in India

    supriya kashyap kashyap3 Jan 2017 2:27 PM IST
    Bengaluru : Masimo announced the launch and availability of the Rad-97™ Pulse-CO Oximeter®* and Next Generation SedLine®* Brain Function Monitoring in...
    Boehringer Ingelheim and China Southeast University collaborate to develop new treatment for hearing loss

    Boehringer Ingelheim and China Southeast University collaborate to develop new treatment for hearing loss

    supriya kashyap kashyap2 Jan 2017 12:11 PM IST
    Germany : Boehringer Ingelheim and China Southeast University Institute of Life Sciences announced the start of a joint research project to develop...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok